Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis.


Journal

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
ISSN: 1749-4486
Titre abrégé: Clin Otolaryngol
Pays: England
ID NLM: 101247023

Informations de publication

Date de publication:
07 2020
Historique:
received: 01 12 2019
revised: 31 03 2020
accepted: 13 04 2020
pubmed: 19 4 2020
medline: 24 8 2021
entrez: 19 4 2020
Statut: ppublish

Résumé

Epiphora is a common clinical sign whose primary cause is post-canalicular lacrimal obstruction. Treatment is both surgical and non-surgical. In the literature, there is some evidence to suggest that some treatments are superior to others, but there are no direct comparative data in this regard. To analyse the success rates of all available treatments to resolve post-canalicular acquired lacrimal obstruction. Systematic review and meta-analysis. A literature search was conducted in the US National Library of Medicine (PubMed), EMBASE, SCOPUS and Cochrane databases with a final search performed in January 2020. The search strategy identified articles published later than 2000 with at least 50 procedures performed both surgically (external dacryocystorhinostomy [EXT-DCR], endoscopic dacryocystorhinostomy [END-DCR] and transcanalicular laser dacryocystorhinostomy [TCL-DCR]) and non-surgically (balloon dacryoplasty [DCP], probing-stenting [SP] and polyurethane stent [PoS]). The primary outcome was functional success, defined as symptom resolution or less than MUNK 2 scale; in addition to this, the influence of adjunctive treatments, such as application of mitomycin C and post-procedural silicone stenting, was evaluated. In total, 14 958 papers were selected, 440 of which were reviewed after screening; 55 were included after full-text review, which involved 9337 procedures. Mean success rate was 48.9% (35.7%-62.3%) for DCP, 54.4% (41.8%-66.5%) for SP, 73.6% (59.7%-84%) for PoS, 80% (75.1%-84%) for TCL-DCR, 89.8% (83.3%-93.9%) for EXT-DCR and 89.5% (87.2%-91.5%) for END-DCR. Among all procedures, a difference was noted between DCP and END-DCR (P < .001), DCP and EXT-DCR (P < .001), SP and END-DCR (P < .001), SP and EXT-DCR (P < .001), END-DCR and PoS (P = .016), and END-DCR and TCL-DCR (P = .001); no differences were noted between END-DCR and EXT-DCR (P = 1.00), EXT-DCR and PoS (P = .121) and EXT-DCR and TCL-DCR (P = .223). Considering surgical procedures, no differences were seen if a silicone stenting was applied, whereas, due to heterogeneity of the literature data, no statistical analysis was feasible for application of mitomycin C. Our analyses suggest that, among all procedures available, END-DCR and EXT-DCR should be considered as treatments of choice to resolve distal acquired lacrimal obstruction.

Sections du résumé

BACKGROUND
Epiphora is a common clinical sign whose primary cause is post-canalicular lacrimal obstruction. Treatment is both surgical and non-surgical. In the literature, there is some evidence to suggest that some treatments are superior to others, but there are no direct comparative data in this regard.
OBJECTIVE OF REVIEW
To analyse the success rates of all available treatments to resolve post-canalicular acquired lacrimal obstruction.
TYPE OF REVIEW
Systematic review and meta-analysis.
SEARCH STRATEGY
A literature search was conducted in the US National Library of Medicine (PubMed), EMBASE, SCOPUS and Cochrane databases with a final search performed in January 2020.
EVALUATION METHOD
The search strategy identified articles published later than 2000 with at least 50 procedures performed both surgically (external dacryocystorhinostomy [EXT-DCR], endoscopic dacryocystorhinostomy [END-DCR] and transcanalicular laser dacryocystorhinostomy [TCL-DCR]) and non-surgically (balloon dacryoplasty [DCP], probing-stenting [SP] and polyurethane stent [PoS]). The primary outcome was functional success, defined as symptom resolution or less than MUNK 2 scale; in addition to this, the influence of adjunctive treatments, such as application of mitomycin C and post-procedural silicone stenting, was evaluated.
RESULTS
In total, 14 958 papers were selected, 440 of which were reviewed after screening; 55 were included after full-text review, which involved 9337 procedures. Mean success rate was 48.9% (35.7%-62.3%) for DCP, 54.4% (41.8%-66.5%) for SP, 73.6% (59.7%-84%) for PoS, 80% (75.1%-84%) for TCL-DCR, 89.8% (83.3%-93.9%) for EXT-DCR and 89.5% (87.2%-91.5%) for END-DCR. Among all procedures, a difference was noted between DCP and END-DCR (P < .001), DCP and EXT-DCR (P < .001), SP and END-DCR (P < .001), SP and EXT-DCR (P < .001), END-DCR and PoS (P = .016), and END-DCR and TCL-DCR (P = .001); no differences were noted between END-DCR and EXT-DCR (P = 1.00), EXT-DCR and PoS (P = .121) and EXT-DCR and TCL-DCR (P = .223). Considering surgical procedures, no differences were seen if a silicone stenting was applied, whereas, due to heterogeneity of the literature data, no statistical analysis was feasible for application of mitomycin C.
CONCLUSIONS
Our analyses suggest that, among all procedures available, END-DCR and EXT-DCR should be considered as treatments of choice to resolve distal acquired lacrimal obstruction.

Identifiants

pubmed: 32304619
doi: 10.1111/coa.13551
doi:

Substances chimiques

Alkylating Agents 0
Mitomycin 50SG953SK6

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-557

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Ali MJ, Iram S, Ali MH, Naik MN. Assessing the outcomes of powered endoscopic dacryocystorhinostomy in adults using the Lacrimal Symptom (Lac-Q) Questionnaire. Ophthalmic Plast Reconstr Surg. 2017;33:65-68.
Juri Mandic J, Ivkic PK, Mandic K, Lesin D, Jukic T, Petrovic JJ. Quality of life and depression level in patients with watery eye. Psychiatr Danub. 2018;30(4):471-477.
Nemet AY. The etiology of epiphora: a multifactorial issue. Semin Ophthalmol. 2016;31:275-279.
Shen GL, Ng JD, Ma XP. Etiology, diagnosis, management and outcomes of epiphora referrals to an oculoplastic practice. Int J Ophthalmol. 2016;9:1751-1755.
Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:649-666.
Al-Qahtani KH, Al Asiri M, Tunio MA, et al. Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases. Clin Ophthalmol. 2014;8:2479-2484.
Alexandrakis G, Hubbell RN, Aitken PA. Nasolacrimal duct obstruction secondary to ectopic teeth. Ophthalmology. 2000;107:189-192.
Alexandrakis G, Tse DT, Rosa RH Jr, Johnson TE. Nasolacrimal duct obstruction and orbital cellulitis associated with chronic intranasal cocaine abuse. Arch Ophthalmol. 1999;117:1617-1622.
Ali MJ. Iodine-131 therapy and nasolacrimal duct obstructions: what we know and what we need to know. Ophthalmic Plast Reconstr Surg. 2016;32:243-248.
Krishna Y, Coupland SE. Lacrimal sac tumors-a review. Asia Pac J Ophthalmol (Phila). 2017;6:173-178.
Tanweer F, Mahkamova K, Harkness P. Nasolacrimal duct tumours in the era of endoscopic dacryocystorhinostomy: literature review. J Laryngol Otol. 2013;127:670-675.
Ali MJ, Paulsen F. Etiopathogenesis of primary acquired nasolacrimal duct obstruction: what we know and what we need to know. Ophthalmic Plast Reconstr Surg. 2019;35(5):426-433.
Park JH, Huh JA, Piao JF, Lee H, Baek SH. Measuring nasolacrimal duct volume using computed tomography images in nasolacrimal duct obstruction patients in Korean. Int J Ophthalmol. 2019;12:100-105.
Ansari SA, Pak J, Shields M. Pathology and imaging of the lacrimal drainage system. Neuroimaging Clin N Am. 2005;15:221-237.
Lefebvre DR, Freitag SK. Update on imaging of the lacrimal drainage system. Semin Ophthalmol. 2012;27:175-186.
Dolman PJ. Comparison of external dacryocystorhinostomy with nonlaser endonasal dacryocystorhinostomy. Ophthalmology. 2003;110:78-84.
Javate R, Pamintuan F. Endoscopic radiofrequency-assisted dacryocystorhinostomy with double stent: a personal experience. Orbit. 2005;24:15-22.
Pelegrinis E, Morphopoulos A, Georgoulopoulos G, Kapogiannis K, Papaspyrou S. Four-year experience with intranasal transilluminating dacryocystorhinostomy using ultrasound. Can J Ophthalmol. 2005;40:627-633.
Velegrakis GA, Prokopakis EP, Panayotaki I, Pagalos AG, Siganos CS, Helidonis ES. Intranasal laser-assisted dacryocystorhinostomy with the use of a surgical microscope. Am J Otolaryngol. 2002;23:272-276.
Selig YK, Biesman BS, Rebeiz EE. Topical application of mitomycin-C in endoscopic dacryocystorhinostomy. Am J Rhinol. 2000;14:205-207.
Lee S, Yen MT. Laser-assisted dacryocystorhinostomy: a viable treatment option? Curr Opin Ophthalmol. 2011;22:413-418.
Mor JM, Matthaei M, Schrumpf H, Koch KR, Bolke E, Heindl LM. Transcanalicular laser dacryocystorhinostomy for acquired nasolacrimal duct obstruction: an audit of 104 patients. Eur J Med Res. 2018;23:58.
Yildirim Y, Kar T, Topal T, et al. Comparison of transcanalicular multidiode laser dacryocystorhinostomy with and without silicon tube intubation. J Ophthalmol. 2016;2016:6719529.
Keith CG. Intubation of the lacrimal passages. Am J Ophthalmol. 1968;65(1):70-74.
Beigi B, O'Keefe M. Results of Crawford tube intubation in children. Acta Ophthalmol (Copenh). 1993;71:405-407.
Fulcher T, O'Connor M, Moriarty P. Nasolacrimal intubation in adults. Br J Ophthalmol. 1998;82(9):1039-1041.
Song HY, Jin YH, Kim JH, et al. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness. Radiology. 1996;200:759-763.
Ilgit ET, Onal B, Coskun B. Interventional radiology in the lacrimal drainage system. Eur J Radiol. 2005;55:331-339.
Patella F, Panella S, Zannoni S, et al. The role of interventional radiology in the treatment of epiphora. Gland Surg. 2018;7(2):103-110.
Athanasiov PA, Prabhakaran VC, Mannor G, Woog JJ, Selva D. Transcanalicular approach to adult lacrimal duct obstruction: a review of instruments and methods. Ophthalmic Surg Lasers Imaging. 2009;40:149-159.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
Ali MJ, Psaltis AJ, Murphy J, Wormald PJ. Outcomes in primary powered endoscopic dacryocystorhinostomy: comparison between experienced versus less experienced surgeons. Am J Rhinol Allergy. 2014;28:514-516.
Bhatia K, Sengupta S, Bhadauria M. Learning curve in external DCR - a trainee's perspective. Nepal J Ophthalmol. 2017;9:121-127.
Lee JJ, Lee HM, Lim HB, Seo SW, Ahn HB, Lee SB. Learning curve for endoscopic endonasal dacryocystorhinostomy. Korean J Ophthalmol. 2017;31:299-305.
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926.
Jeremy Howick IC, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. The 2011 Oxford CEBM Levels of Evidence (Introductory Document). Oxford, UK: Oxford Centre for Evidence-Based Medicine; 2011.
Dekkers OM, Egger M, Altman DG, Vandenbroucke JP. Distinguishing case series from cohort studies. Ann Intern Med. 2012;156:37-40.
Mathes T, Pieper D. Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload. BMC Med Res Methodol. 2017;17:107.
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Munk PL, Lin DT, Morris DC. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus. Radiology. 1990;177:687-690.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014. URL www.R-project.org
Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153-160.
Farzampour S, Fayazzadeh E, Mikaniki E. Endonasal laser-assisted microscopic dacryocystorhinostomy: surgical technique and follow-up results. Am J Otolaryngol. 2010;31:84-90.
Fayers T, Dolman PJ. Bicanalicular silicone stents in endonasal dacryocystorhinostomy: results of a randomized clinical trial. Ophthalmology. 2016;123:2255-2259.
Walker RA, Al-Ghoul A, Conlon MR. Comparison of nonlaser nonendoscopic endonasal dacryocystorhinostomy with external dacryocystorhinostomy. Can J Ophthalmol. 2011;46:191-195.
Ciampi JJ, Lanciego C, Navarro S, et al. Treating epiphora in adults with the Wilhelm plastic nasolacrimal stent: mid-term results of a prospective study. Cardiovasc Intervent Radiol. 2011;34:124-131.
Kang SG, Song HY, Lee DH, Choi JY, Ahn HS. Nonsurgically placed nasolacrimal stents for epiphora: long-term results and factors favoring stent patency. J Vasc Interv Radiol. 2002;13:293-300.
Ozturk S, Konuk O, Ilgit ET, Unal M, Erdem O. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing? Ophthalmic Plast Reconstr Surg. 2004;20:130-135.
Paul L, Pinto I, Vicente JM, Armendariz A, Moreno G, Baraibar MC. Nasolacrimal stents in the treatment of epiphora: long-term results. J Vasc Interv Radiol. 2002;13:83-88.
Preziosi P, Di Primio M, Erdembileg T, et al. Treatment of lacrimal stenoses obstructions with interventional radiology: immediate and 5-year follow-up results. Radiol Med. 2008;113:1211-1218.
Huang J, Malek J, Chin D, et al. Systematic review and meta-analysis on outcomes for endoscopic versus external dacryocystorhinostomy. Orbit. 2014;33:81-90.
Jawaheer L, MacEwen CJ, Anijeet D. Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction. Cochrane Database Syst Rev. 2017;2:CD007097.
Leong SC, Macewen CJ, White PS. A systematic review of outcomes after dacryocystorhinostomy in adults. Am J Rhinol Allergy. 2010;24:81-90.
Mandeville JT, Woog JJ. Obstruction of the lacrimal drainage system. Curr Opin Ophthalmol. 2002;13:303-309.
Lanciego C, De Miguel S, Padilla M, Perea M, Rodriguez-Merlo R, Garcia-Garcia L. Nasolacrimal stenting: toward improving outcomes with a simple modification of the song stent. Cardiovasc Intervent Radiol. 2006;29:586-594.
Dogan R, Meric A, Ozsütcü M, Yenigun A. Diode laser-assisted endoscopic dacryocystorhinostomy: a comparison of three different combinations of adjunctive procedures. Eur Arch Otorhinolaryngol. 2013;270:2255-2261.
Tsirbas A, Wormald PJ. Mechanical endonasal dacryocystorhinostomy with mucosal flaps. Otolaryngol Clin North Am. 2006;39:1019-1036.
Wormald PJ. Powered endoscopic dacryocystorhinostomy. Otolaryngol Clin North Am. 2006;39:539-549.
Aksoy Y, Yildirim Y, Topal T, Cesmeci E, Cakir Y. Functional success evaluation of lacrimal drainage system by dacryoscintigraphy after transcanalicular diode laser dacryocystorhinostomy. Indian J Ophthalmol. 2018;66:1161-1164.
Gupta S, Kumar A, Agarwal S, Pandey P. Transcanalicular laser dacryocystorhinostomy using low energy 810 nm diode laser. Oman J Ophthalmol. 2012;5:171-174.
Hofmann T, Lackner A, Muellner K, Luxenberger W, Wolf G. Endolacrimal KTP laser-assisted dacryocystorhinostomy. Arch Otolaryngol Head Neck Surg. 2003;129:329-332.
Pal VK, Agrawal A, Suman S, Pratap VB. Transcanalicular endoscope combined laser-assisted dacryocystorhinostomy. Oman J Ophthalmol. 2013;6:99-102.
Green R, Gohil R, Ross P. Mucosal and lacrimal flaps for endonasal dacryocystorhinostomy: a systematic review. Clin Otolaryngol. 2017;42:514-520.
Sobel RK, Aakalu VK, Wladis EJ, Bilyk JR, Yen MT, Mawn LA. A Comparison of endonasal dacryocystorhinostomy and external dacryocystorhinostomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(11):1580-1585.
The National Institute of Health and Clinical Excellence. Interven- tional Procedure Overview of Endoscopic Dacryocystorhinostomy. London, UK: The National Institute of Health and Clinical Excellence; 2004.
Woog JJ, Kennedy RH, Custer PL, Kaltreider SA, Meyer DR, Camara JG. Endonasal dacryocystorhinostomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2001;108:2369-2377.
Watkins LM, Janfaza P, Rubin PA. The evolution of endonasal dacryocystorhinostomy. Surv Ophthalmol. 2003;48:73-84.
Trimarchi M, Giordano Resti A, Bellini C, Forti M, Bussi M. Anastomosis of nasal mucosal and lacrimal sac flaps in endoscopic dacryocystorhinostomy. Eur Arch Otorhinolaryngol. 2009;266:1747-1752.
Trimarchi M, Giordano Resti A, Vinciguerra A, Dane G, Bussi M. Dacryocystorhinostomy: evolution of endoscopic techniques after 498 cases. Eur J Ophthalmol. 2019. https://doi.org/10.1177/1120672119854582
Kshirsagar RS, Vu PQ, Liang J. Endoscopic versus external dacryocystorhinostomy: temporal and regional trends in the United States Medicare population. Orbit. 2019;38(6):453-460.
Devoto MH, Zaffaroni MC, Bernardini FP, de Conciliis C. Postoperative evaluation of skin incision in external dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2004;20:358-361.
Ng DS, Chan E. Techniques to minimize skin incision scar for external dacryocystorhinostomy. Orbit. 2016;35:42-45.
Wadwekar B, Hansdak A, Nirmale SD, Ravichandran K. Cutaneous scar visibility after external dacryocystorhinostomy: a comparison of curvilinear and W shaped incision. Saudi J Ophthalmol. 2019;33:142-147.
Cheng SM, Feng YF, Xu L, Li Y, Huang JH. Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis. PLoS ONE. 2013;8:e62737.
Feng YF, Yu JG, Shi JL, Huang JH, Sun YL, Zhao YE. A meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C. Ophthalmic Epidemiol. 2012;19:364-370.
Nair AG, Ali MJ. Mitomycin-C in dacryocystorhinostomy: from experimentation to implementation and the road ahead: a review. Indian J Ophthalmol. 2015;63(4):335-339.
Qian Z, Zhang Y, Fan X. Clinical outcomes of dacryocystorhinostomy with or without intraoperative use of mitomycin C: a systematic review and meta-analysis. J Ocul Pharmacol Ther. 2014;30:615-624.
Ing EB, Bedi H, Hussain A, et al. Meta-analysis of randomized controlled trials in dacryocystorhinostomy with and without silicone intubation. Can J Ophthalmol. 2018;53:466-470.
Kang MG, Shim WS, Shin DK, Kim JY, Lee JE, Jung HJ. A systematic review of benefit of silicone intubation in endoscopic dacryocystorhinostomy. Clin Exp Otorhinolaryngol. 2018;11:81-88.
Kim DH, Kim SI, Jin HJ, Kim S, Hwang SH. The clinical efficacy of silicone stents for endoscopic dacryocystorhinostomy: a meta-analysis. Clin Exp Otorhinolaryngol. 2018;11:151-157.
Sarode D, Bari DA, Cain AC, Syed MI, Williams AT. The benefit of silicone stents in primary endonasal dacryocystorhinostomy: a systematic review and meta-analysis. Clin Otolaryngol. 2017;42:307-314.
Xie C, Zhang L, Liu Y, Ma H, Li S. Comparing the success rate of dacryocystorhinostomy with and without silicone intubation: a trial sequential analysis of randomized control trials. Sci Rep. 2017;7:1936.

Auteurs

Alessandro Vinciguerra (A)

Division of Head and Neck department, Otorhinolaryngology unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Alessandro Nonis (A)

CUSSB, University Centre for Statistics in the Biomedical Sciences, San Raffaele Hospital, Vita-Salute University, Milano, Italy.

Antonio Giordano Resti (A)

Division of Head and Neck department, Ophthalmologic unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Mario Bussi (M)

Division of Head and Neck department, Otorhinolaryngology unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Matteo Trimarchi (M)

Division of Head and Neck department, Otorhinolaryngology unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH